124 Afleveringen

  1. #44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

    Gepubliceerd: 17-9-2021
  2. #43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

    Gepubliceerd: 27-8-2021
  3. #42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

    Gepubliceerd: 20-8-2021
  4. #41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

    Gepubliceerd: 16-7-2021
  5. #40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

    Gepubliceerd: 18-6-2021
  6. #39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics

    Gepubliceerd: 21-5-2021
  7. #38 – You're KID-ding! Myths in ID Pediatrics

    Gepubliceerd: 23-4-2021
  8. #37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

    Gepubliceerd: 16-4-2021
  9. #36 – Monoclonal Antibodies: Gateway Drugs for Future Care Delivery Models

    Gepubliceerd: 26-3-2021
  10. #35 – Oral Beta-Lactams, Are We Serious?

    Gepubliceerd: 19-3-2021
  11. #34 – The New Scoop on Poop: Updates in the Management of C. difficile infections

    Gepubliceerd: 19-2-2021
  12. #33 – A Lung Time Coming: Controversies in Community Acquired Pneumonia

    Gepubliceerd: 15-1-2021
  13. #32 – Unsolicited Advice: An Honest Discussion of Burnout in Stewardship

    Gepubliceerd: 18-12-2020
  14. #31 – “Mind the Gap”: Antimicrobial Stewardship at Transitions of Care

    Gepubliceerd: 20-11-2020
  15. #30 – Is More Better? The Role of Combination Therapy for MRSA

    Gepubliceerd: 9-10-2020
  16. #29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2

    Gepubliceerd: 11-9-2020
  17. #28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1

    Gepubliceerd: 4-9-2020
  18. #27 – Expert Updates in Gram Negative Resistance: Q&A Session

    Gepubliceerd: 31-7-2020
  19. #26 – OPAT - The Final Frontier, Part 2

    Gepubliceerd: 19-6-2020
  20. #25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More

    Gepubliceerd: 18-6-2020

5 / 7

The SIDP Podcast

Visit the podcast's native language site